# Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.

> **NCT01329276** · PHASE4 · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 10 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Symbicort® forte Turbohaler®

## Key facts

- **NCT ID:** NCT01329276
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-11
- **Final completion:** 2011-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2011-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329276, "Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01329276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*